Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

Cystadrops in Pediatric Cystinosis Patients From Six Months to Less Than Two Years Old (SCOB2)

In this page

Clinical Trial

NCT04125927 Completed
Cystadrops in Pediatric Cystinosis Patients From Six Months to Less Than Two Years Old (SCOB2)

Open-label, Single-arm, Multicenter Study to Assess the Safety of Cystadrops® in Pediatric Cystinosis Patients From 6 Months to Less Than 2 Years Old

Phase 3
Interventional

Disease

Disease type

Other

Paediatric clinical trials

Orphan drug recognition

Yes

Patient type

Adult

Children

Inclusion / Exclusion

Opening date

01/09/2020

Closing date

23/12/2022

Inclusion criteria :

More

Exclusion criteria :

More

Funding

other

Members involved

Others investigators

Pr Ingele Casteels

Representative

Belgium

See more

Pr Dominique BREMOND-GIGNAC

Representative

France

Anterior Segment Rare Eye Diseases (WG4), CPMS & Digital Medecine (TWG10), Genetic Diagnostics (TWG6), Low Vision Daily Life and Patients Groups (TWG5), National Integration (TWG9), Neuro-Ophthalmology Rare Diseases (WG2), Pediatric Ophthalmology Rare Diseases (WG3), Registries & Epidemiology (TWG7), Research (TWG8), Retinal Rare Eye Diseases (WG1)
Working Group Leader
See more

Dr Luca Buzzonetti

Representative

Italy

Anterior Segment Rare Eye Diseases (WG4)
See more

ERN EYE member investigating site

HCP : Principal investigators

OPHTARA – AP-HP, Hôpital Necker-Enfants Malades, Paris, France

Adress

Service d'ophtalmologieBât. Lecourbe - RC149 rue de Sèvres

75 015 Paris

France